Artificial intelligence (AI)-powered imaging for objective psoriasis severity assessment at home: Feasibility and reliability in a randomized clinical trial
Journal of the American Academy of Dermatology · 2026-10 · 95 (4) · 1182-1184
DOI: 10.1016/j.jaad.2026.06.047 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Academy of Dermatology, 2026-10. Verfasst von Mariona Oliver und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Human Drug Research, Leiden, The Netherlands; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Le…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NWO.
Abstract (Originalsprache)
Artificial intelligence (AI)-powered imaging for objective psoriasis severity assessment at home: Feasibility and reliability in a randomized clinical trial Key Message: Patient-captured smartphone images analyzed by AI, reliably detect and quantify treatment-related changes consistent with physician scoring.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Human Drug Research, Leiden, The Netherlands; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
- SCARLETRED Holding GmbH, Vienna, Austria.
- Centre for Human Drug Research, Leiden, The Netherlands.
- Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
- MAASTRO (Dept of Radiation Oncology), GROW Research Institute of Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
- Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. Electronic address: d.m.w.balak@lumc.nl.
Förderung
- NWO
Zitieren
APA
Oliver, M., Molnarova, M., Bergmans, M., Ranjan, R., Exadaktylos, V., Niemeyer van der Kolk, T., Seyger, M. M. B., Wee, L., Balak, D. M. W., van Doorn, M. B. A., Rissmann, R., Schnidar, H., Rousel, J., & Next Generation ImmunoDermatology Consortium (NGID) (2026). Artificial intelligence (AI)-powered imaging for objective psoriasis severity assessment at home: Feasibility and reliability in a randomized clinical trial. Journal of the American Academy of Dermatology, 95(4), 1182-1184. https://doi.org/10.1016/j.jaad.2026.06.047
Vancouver
Oliver M, Molnarova M, Bergmans M, Ranjan R, Exadaktylos V, Niemeyer van der Kolk T, et al. Artificial intelligence (AI)-powered imaging for objective psoriasis severity assessment at home: Feasibility and reliability in a randomized clinical trial. Journal of the American Academy of Dermatology. 2026;95(4):1182-1184. doi:10.1016/j.jaad.2026.06.047
BibTeX
@article{Oliver2026,
author = {Oliver, Mariona and Molnarova, Monika and Bergmans, Menthe and Ranjan, Rahul and Exadaktylos, Vasileios and Niemeyer van der Kolk, Tessa and Seyger, Marieke M B and Wee, Leonard and Balak, Deepak M W and van Doorn, Martijn B A and Rissmann, Robert and Schnidar, Harald and Rousel, Jannik and Next Generation ImmunoDermatology Consortium (NGID), Next Generation ImmunoDermatology Consortium (NGID)},
title = {Artificial intelligence (AI)-powered imaging for objective psoriasis severity assessment at home: Feasibility and reliability in a randomized clinical trial},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {4},
pages = {1182--1184},
doi = {10.1016/j.jaad.2026.06.047}
}
EUVIMED